1. ？Bergamaschi S, Morato E, BazzoM, et al. Tumor markers are elevated in patients with rheumatoid arthritis and do not indicate present of cancer. Int J Rheum Dis, 2012, 15:179-182.
7. Bilgici A, Ulusoy H, Kuru O, et al.Pulmonary involvement in rheumatoid arthritis.Rheumatol Int, 2005, 25:429-435.
[4]
9. Lee DM, Schur PH. Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis, 2003, 62:870-874.
[5]
10. van Boekel MA, Vossenaar ER, van den Hoogen FH, et al. Autoantibody systems in rheumatoid arthritis:specificity, sensitivity and diagnostic value. Arthritis Res, 2002, 4:87-93.
[6]
13. Szekanecz E, Sandor Z, Antal-Szalmas P, et al. Increased production of the soluble tumor-associated antigens CA19-9, CA125, andCA15-3 in rheumatoid arthritis:potentialadhesion molecules in synovial inflammation? Ann N Y Acad Sci, 2007, 1108:359-371.
[7]
14. Amoura Z,Duhaut P, Huong DL, et al. Tumor antigen markers for he detection of solid cancers in inflammatory myopathies. Cancer Epidemiol Biomarkers Prev, 2005, 14:1279-1282.
[8]
15. Akira M, Sakatani M, Hara H. Thin-section CT findings in rheumatoid arthritis-associated lung disease:CT patterns and their courses. J Comput Assist Tomogr, 1999, 23:941-948.
[9]
2. Young A, Koduri G.Extra-articular manifestations and complications of rheumatoid arthritis.Best Pract Res Clin Rheumatol, 2007, 21:907-927.
[10]
3. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association1987revisedcriteria for the classification of rheumatoid arthritis. Arthritis Rheum, 1988, 31:315-324.
[11]
5. Lee HK,Kim DS,Yoo B, et al. Histopa thologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease.Chest,2005, 127:2019-2027.
8. Habib HM, Eisa AA, Arafat WR, et al. Pulmonary involvement in early rheumatoid arthritis patients. Clin Rheumatol, 2011, 30:217-221.
[14]
11. Inui N, Enomoto N, Suda T, et al. Anticyclic citrullinated peptide antibodies in lung diseases associated with rheumatoid arthritis. Clin Biochem, 2008, 41:1074-1077.
[15]
12. Korkmaz C, Us T, Kasifoglu T, et al. Anti-cyclic citrullinated pep-tide (CCP) antibodies inpatients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations. Clin Biochem, 2006, 39:961-965.
[16]
16. Dawson JK, Fewins HE, Desmond J,et al. Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis. Ann Rheum Dis,2002, 61:517-521.
